Registered Uganda · NDA

TENOFOVIR DISOPROXIL FUMARATE + LAMIVUDINE + DOLUTEGRAVIR SODIUM

NDA/MAL/HDP/9524 ORAL SOLID ORDINARY TABLETS 300 MG + 300 MG + 50 MG

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
NDA/MAL/HDP/9524
Registration date
24/02/2021
Expiry date
-
Status
Registered
Active ingredient
-
Strength
300 MG + 300 MG + 50 MG
Pack size
1.0X1.0X30.0 TABLET BOTTLE,1.0X90.0 TABLET BOTTLE
Therapeutic class
-
Country of origin
INDIA| KENYA
Manufacturer location
QM56+MH6, Rungiri, Kenya

Source: National Drug Authority · fetched 2026-04-21 17:37:10 · updated 2026-09-12 04:00:21

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.